We develop therapeutics that we are confident will provide effective solutions to currently unmet needs of patients with chronic diseases. Our strategy is to search for and license mid- to late-stage molecules that fulfill our criteria for further development. These criteria include sound scientific rationale, strong preclinical and clinical study results, defined regulatory pathway to approval and robust IP protection.
Powered by science, driven by values
We are committed to serving our patients with innovative and differentiated therapeutics that will improve their quality of life and clinical outcome.
We come to work passionate about what we do and with a sense of urgency to bring these therapeutics to our patients.
We are committed as an organization to constant improvement and learning.
We will always deal with our patients, community, investors and colleagues with respect and honesty.